| NCT06588023
| Prevalence of Blood Pressure Complications During Cesarean Section in Pre-eclamptic Patients (HOPE) | No drug interventions | Not Available | Not Available | not_yet_recruiting |
| NCT06580405
| A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia | No drug interventions | treatment | Not Available | not_yet_recruiting |
| NCT03232359
| Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome | No drug interventions | Not Available | Not Available | completed |
| NCT03246542
| Promising Bimarker Prediction of Outcome of HELLP Syndrome. | No drug interventions | Not Available | Not Available | completed |
| NCT06385600
| Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia. | | treatment | Not Available | not_yet_recruiting |
| NCT03661775
| Serum Magnesium Level Administration in Severe Pre-eclampsia Obese Pregnancy | | prevention | Not Available | completed |
| NCT02314286
| Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following Delivery | | treatment | 1 / 2 | unknown_status |
| NCT05310929
| Nitroglycerin Versus Labetalol in Acute Severe Pre-eclampsia | | treatment | Not Available | completed |
| NCT01766089
| Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery | | prevention | 2 | completed |
| NCT06126068
| Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia. | | treatment | Not Available | completed |
| NCT06219109
| Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia | No drug interventions | Not Available | Not Available | recruiting |
| NCT05176652
| Ultrasonographic Diameter of Optic Nerve Sheath in Fluid Assessment in Severe Preeclamptic Patients | No drug interventions | Not Available | Not Available | unknown_status |
| NCT02164370
| Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach | No drug interventions | Not Available | Not Available | completed |
| NCT05283473
| Serum Magnesium Concentration in Magnesium Sulfate Therapy for Severe Preeclampsia | No drug interventions | Not Available | Not Available | recruiting |
| NCT03318211
| Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial | | treatment | 4 | unknown_status |
| NCT03761888
| Nicardipine and Labetalol Effects on Cerebral Hemodynamics in Preeclampsia | No drug interventions | Not Available | Not Available | unknown_status |
| NCT05594056
| Transorbital Ultrasound of Optic Nerve Sheath Diameter Between Healthy Pregnant Women and Those With Severe Preeclampsia. | No drug interventions | diagnostic | Not Available | completed |
| NCT06359015
| Metformin and Esomeprazole in Preterm Pre-eclampsia | | treatment | 4 | active_not_recruiting |
| NCT04660032
| Nudge to Drive Transitions of Care | No drug interventions | health_services_research | Not Available | completed |
| NCT04392375
| Nifedipine XL Versus Placebo for the Treatment of Preeclampsia With Severe Features During Induction of Labor | | treatment | 4 | completed |
| NCT03451266
| Effects of Vitamin C Administration on Extravascular Lung Water in Patients With Severe Features of Preeclampsia | | treatment | 1 | completed |
| NCT05610774
| Optic Nerve Sheath Diameter in Pre-Eclamptic Parturient Receiving Magnesium Sulfate Combined With Dexmedetomidine | | prevention | Not Available | recruiting |
| NCT05232994
| Metformin and Esomeprazole For Preterm Pre-eclampsia | | prevention | 1 | not_yet_recruiting |
| NCT03978767
| Preeclampsia And Nonsteroidal Drugs for Analgesia: a Randomized Non Inferiority Trial | | treatment | 2 | recruiting |
| NCT04794855
| Risk Prediction Model of Preeclampsia | No drug interventions | Not Available | Not Available | enrolling_by_invitation |
| NCT03210350
| Effect of Magnesium Sulphate on the Intracranial Pressure of Preeclamptic Patients | No drug interventions | Not Available | Not Available | completed |
| NCT04756661
| Uterotonics for Severe Preeclampsia | | prevention | Not Available | completed |
| NCT04243278
| Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC) | | basic_science | 0 | terminated |
| NCT04311749
| Expanded NIPT for Pregnancy Complications | No drug interventions | Not Available | Not Available | active_not_recruiting |
| NCT04855513
| Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial | | prevention | Not Available | unknown_status |
| NCT04236258
| Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period | | treatment | 4 | completed |
| NCT04103489
| The Use of Eculizumab in HELLP Syndrome | | treatment | 1 | completed |
| NCT06373367
| Preeclampsia Educational Program Study (PrEPS) | No drug interventions | other | Not Available | not_yet_recruiting |
| NCT06360601
| Intravenous Labetalol Versus Hydralazine in Preeclampsia | | prevention | 1 / 2 | active_not_recruiting |
| NCT03815110
| Preeclampsia Risk Assessment: Evaluation of Cut-offs to Improve Stratification | No drug interventions | Not Available | Not Available | completed |
| NCT01538147
| Restless Leg Syndrome and Severe Preeclampsia | No drug interventions | Not Available | Not Available | completed |
| NCT04058405
| Risk Prediction Models for Adverse Maternal and Neonatal Outcomes in Preeclampsia | No drug interventions | Not Available | Not Available | completed |
| NCT03744988
| Serum Androgen Levels as a Marker for the Severity of Preeclampsia | No drug interventions | Not Available | Not Available | unknown_status |
| NCT06265415
| Comparative Study of Intravenous Labetalol Versus Intravenous Nitroglycerin Versus Sublingual Nifedipine | | treatment | Not Available | not_yet_recruiting |
| NCT02379832
| Pre-Eclampsia And Growth Restriction: a Longitudinal Study | No drug interventions | Not Available | Not Available | completed |
| NCT01382732
| Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe Preeclampsia | | prevention | 3 | unknown_status |
| NCT03008616
| Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia | | treatment | 2 / 3 | terminated |
| NCT02189148
| First-trimester Prediction of Preeclampsia | No drug interventions | Not Available | Not Available | completed |
| NCT01906567
| İs There a Relationship Between Severity of Preeclampsia and Maternal Heavy Metal Levels? | No drug interventions | Not Available | Not Available | unknown_status |
| NCT01538121
| Antiphospholipid Antibodies and Early Severe Preeclampsia. | No drug interventions | Not Available | Not Available | unknown_status |
| NCT01408979
| Effectiveness Study of Short Course of Magnesium Sulfate for Severe Preeclamsia | | treatment | 4 | completed |
| NCT06486025
| Protocols for Magnesium Sulfate Maintenance Dose in Overweight and Obese Women Diagnosed With Preeclampsia | | treatment | 1 / 2 | not_yet_recruiting |
| NCT03164304
| Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsia | | treatment | 4 | completed |
| NCT04725812
| Complement Regulation to Undo Systemic Harm in Preeclampsia | | treatment | 2 | terminated |